It appears to me that Prime Health is following the industry trend of allowing lower BMI patients to be accepted so long as they have another qualifying medical condition that would necessitate it
Available from: [Accessed 4 Mar 2025]
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 189,00 per year only 15,75 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
These early changes are subtle but encouraging
Tirzepatide users (Zepbound / Mounjaro) also reported shedding more often than placebo, but again the rates were modest
Notably, the deletion of lipogenic enzymes in the liver, such as acetyl-CoA carboxylase 1/2 (ACC1/2), has been reported to liberate NADPH for antioxidant processes, including GSH regeneration 87
